TNBCtype statistics

info info

Citations per year

Number of citations per year for the bioinformatics software tool TNBCtype

Tool usage distribution map

This map represents all the scientific publications referring to TNBCtype per scientific context
info info

Associated diseases

This word cloud represents TNBCtype usage per disease context

Popular tool citations

chevron_left Prognostic biomarker identification chevron_right
Want to access the full stats & trends on this tool?


TNBCtype specifications


Unique identifier OMICS_19773
Name TNBCtype
Alternative name Triple-Negative Breast Cancer type
Interface Web user interface
Restrictions to use None
Input data Gene expression values.
Input format CSV
Computer skills Basic
Stability Stable
Maintained Yes


  • person_outline Jennifer Pietenpol
  • person_outline Xi Chen

Additional information

Publication for Triple-Negative Breast Cancer type

TNBCtype citations


How shall we treat early triple negative breast cancer (TNBC): from the current standard to upcoming immuno molecular strategies

PMCID: 5950702
PMID: 29765774
DOI: 10.1136/esmoopen-2018-000357

[…] e majority of TNBC subtypes other than MSL and LAR were classified as BLBC. Recently, Lehmann et al revised their previous subclassification to a more concise system consisting of only four subtypes (TNBCtype-4): BL1, BL2, M and LAR. A noticeable remark from this study was that the IM phenotype was not an isolated molecular subtype, but can exist within all molecular subtypes to varying degrees. B […]


Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine method

PMCID: 5696233
PMID: 29190967
DOI: 10.18632/oncotarget.21669
call_split See protocol

[…] -derived TNBC gene expression (RNAseq) data for primary tumors were obtained from The Cancer Genome Atlas (TCGA) [] via extraction from the UCSC Cancer Genome Browser []. For each patient sample, the TNBCtype webtool [] was used to classify that sample into the subtype according to Lehmann et al []. Differential gene expression analysis (DGEA) was performed in R [] where one TNBC patient subtype g […]


Reverse phase protein array identification of triple negative breast cancer subtypes and comparison with mRNA molecular subtypes

PMCID: 5642571
PMID: 29050296
DOI: 10.18632/oncotarget.19719

[…] the most correlation was seen in only the BL1/2 subtypes, and we couldn’t identify the 6 molecular subtypes using functional proteomics analysis.Lehmann et al refined TNBC molecular subtypes from 6 (TNBCtype) into 4 (TNBCtype-4) tumor-specific subtypes (BL1, BL2, M, and LAR) because they found significant evidence that the IM and MSL TNBC subtypes represent tumors with substantial numbers of infi […]


Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD 2076 in Preclinical Models of p53 Mutated Triple Negative Breast Cancer

PMCID: 5430301
PMID: 28555173
DOI: 10.3389/fonc.2017.00094
call_split See protocol

[…] To predict the TNBC subtypes of the PDX models, we used the TNBCtype web tool ( (). RNA-seq data for these models were uploaded to the TNBCtype web tool. Based on the gene expression profiles, the TNBCtype was assigned to the […]


Single cell RNA seq enables comprehensive tumour and immune cell profiling in primary breast cancer

Nat Commun
PMCID: 5424158
PMID: 28474673
DOI: 10.1038/ncomms15081

[…] l correlations; comparisons with immunofluorescence staining results; comparisons of immune marker expression; and application of self-normalizing tools such as Gene Set Variation Analysis (GSVA) and TNBCtype. […]


Comparison of triple negative breast cancer molecular subtyping using RNA from matched fresh frozen versus formalin fixed paraffin embedded tissue

BMC Cancer
PMCID: 5379658
PMID: 28376728
DOI: 10.1186/s12885-017-3237-1

[…] e extended to FFPE samples profiled by RNA-seq, we performed subtyping on gene expression data derived from RNA prepared from 21 matched FF and FFPE pairs and sequenced on a HiSeq or MiSeq. Using the TNBCtype algorithm on samples sequenced on the HiSeq, we obtained subtype calls for 10 FF and 9 FFPE samples (with 9 sample pairs having calls for both FF and FFPE).The concordance rate was 67% (6 of […]

Want to access the full list of citations?
TNBCtype institution(s)
Department of Biostatistics, Vanderbilt University, Nashville, TN, USA; Center for Quantitative Sciences, Vanderbilt University, Nashville, TN, USA; Department of Biochemistry, Vanderbilt University, Nashville, TN, USA; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA
TNBCtype funding source(s)
Supported by NIH grants CA068485; CA95131 (Specialized Program of Research Excellence in Breast Cancer); CA148375; CA105436; CA070856; CA009385; American Cancer Society Grant #PF-10-226-01-TBG; and Komen Foundation grant SAC110030.2.0

TNBCtype reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review TNBCtype